RESULTS	Within-group changes from baseline to 12-week revealed significant increases in OxPL/apoB and reductions in small-dense LDL , MDA-LDL , and lipoprotein-associated phospholipase A ( 2 ) measured on circulating apoB particles ( Lp-PLA ( 2 ) / apoB ) in both groups and significant reductions in OxPL/apoAI in the atorvastatin group .\